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Abstract 21	
Histone exchange and histone post-translational modifications play important roles in the 22	
regulation of DNA metabolism, by re-organizing the chromatin configuration. We previously 23	
demonstrated that the histone variant H2A.Z-2 is rapidly exchanged at damaged sites after 24	
DNA double strand break induction in human cells. In yeast, the small ubiquitin-like modifier 25	
(SUMO) modification of H2A.Z is involved in the DNA damage response. However, whether 26	
the SUMO modification regulates the exchange of human H2A.Z-2 at DNA damage sites 27	
remains unclear. Here, we show that H2A.Z-2 is SUMOylated in a damage-dependent manner, 28	
and the SUMOylation of H2A.Z-2 is suppressed by the depletion of the SUMO E3 ligase, 29	
PIAS4. Moreover, PIAS4 depletion represses the incorporation and eviction of H2A.Z-2 at 30	
damaged sites. These findings demonstrate that the PIAS4-mediated SUMOylation regulates 31	
the exchange of H2A.Z-2 at DNA damage sites. 32	
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Introduction 37	
 38	
DNA double strand breaks (DSBs) are one of the most serious forms of DNA damage. DSBs 39	
can be lethal to a cell, and errors in the repair process lead to genomic instability and 40	
tumorigenesis. There are two major repair pathways for DSB repair, homologous 41	
recombination (HR) and non-homologous end joining (NHEJ). 1 HR ensures accurate repair 42	
by using the undamaged sister chromatid or homologous chromosome as the template. Several 43	
lines of evidence suggested that higher-order chromatin structures are reorganized by post-44	
translational protein modifications and/or histone protein exchange at damaged sites to 45	
facilitate DNA damage repair. The best-known example is the phosphorylation of the histone 46	
H2A variant H2AX, called γH2AX and a marker of DSBs, which triggers almost all DNA 47	
damage responses, including various chromatin dynamics for DSB repair. 2  In budding yeast, 48	
the SWR1 chromatin-remodeling complex catalyzes the replacement of H2A with the H2A 49	
variant H2A.Z. 3 The SWR1 complex-dependent incorporation of H2A.Z is required for DSB 50	
relocation to the nuclear periphery. 4 In mammalian cells, the NuA4 complex promotes the 51	
rapid exchange of H2A for H2A.Z at DSBs, suggesting a role of H2A.Z in the regulation of 52	
DNA repair in human cells. 5 However, the function of H2A.Z in the reorganization of damaged 53	
chromatin in human cells is still unclear. 54	
 H2A.Z is an evolutionarily well-conserved histone variant from yeast to humans. 6 The 55	
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H2A.Z protein levels are ~10% of the total H2A complement. In mice, deletion of the H2A.Z 56	
gene leads to early embryonic lethality. 7 The absence of H2A.Z in yeast increases the 57	
sensitivity to genotoxic agents. 8 H2A.Z is highly expressed in progressive breast cancer, 58	
bladder cancer and malignant melanoma. 9-11 While H2A.Z is associated preferentially with the 59	
promoters of repressed genes, its K14 acetylated form is enriched at the promoters of active 60	
genes. 12 A single gene (HTZ1) encodes H2A.Z in budding yeast, and two genes have been 61	
identified in vertebrates. These were named H2A.Z-1 (previously H2A.Z) and H2A.Z-2 62	
(previously H2A.F/Z or H2A.V). 13 H2A.Z-2-deficient cells proliferate more slowly than 63	
H2A.Z-1-deficient cells. 14 We previously reported that RAD51 focus formation, a hallmark of 64	
recombinational repair, was disturbed in H2A.Z-2-deficient cells but not in H2A.Z-1-deficient 65	
cells. 15 We also found that H2A.Z-2 is exchanged at DSB sites immediately after the induction 66	
of DSBs after ionizing radiation.15 However, the means by which the exchange of H2A.Z-2 is 67	
facilitated at damaged sites still remain unclear. 68	
 Histones and their variants can be modified post-translationally, by acetylation, 69	
methylation, and phosphorylation. 16-18 They also can be conjugated to small proteins, such as 70	
ubiquitin and small ubiquitin-like modifier (SUMO). 19, 20 SUMOylation is a post-translational 71	
modification involved in cell cycle progression, subcellular transport, transcription and DNA 72	
repair. 21 Chromosome-wide RAD51 spreading and SUMOylated H2A.Z are required for the 73	
movement of persistent DSBs to the nuclear periphery in yeast. 22 In mammalian cells, SUMO 74	
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proteins accumulate at DSB sites by mechanisms requiring MDC1, 53BP1 and BRCA1. 75	
Furthermore, the SUMO E3-ligases PIAS1 and PIAS4 accumulate at DSB sites to promote 76	
DNA repair by homologous recombination. 23 We reported that the RAD51 accumulation at 77	
damaged sites is dependent on its SUMO interacting motif (SIM). 24 However, it remains to be 78	
clarified whether SUMOylation is involved in the regulation of the exchange of human H2A.Z-79	
2 at damaged sites. 80	
 Here, we showed that H2A.Z-2 is SUMOylated by PIAS4 in a damage-dependent 81	
manner in human cells. The depletion of PIAS4, but not PIAS1, significantly repressed the 82	
increase of the H2A.Z-2 mobility at sites containing DNA damage after microirradiation. These 83	
findings suggest that the SUMOylation of H2A.Z-2 is required for its exchange at sites of DNA 84	
damage. 85	
 86	
  87	
	 6	
Results 88	
To assess whether human H2A.Z-2 is SUMOylated after the induction of DNA damage, we 89	
established HeLa cells stably expressing C-terminally FLAG-HA-tagged H2A.Z-2. The 90	
histone H2A.Z-2 proteins were purified from the nuclear extracts of these cells before and 91	
after ionizing radiation (IR), as previously described. 25  We subsequently performed the 92	
immunoblotting analysis using an anti-H2A.Z antibody, to confirm the presence of H2A.Z-2 93	
proteins in the purified complex, and observed slowly migrating bands (arrows, Fig. 1) in 94	
addition to those with the expected size around 21.5 kDa, suggesting the posttranslational 95	
modification of H2A.Z-2. These slowly migrating bands were also detected by the 96	
immunoblotting using an antibody against SUMO1, and considering their molecular weight, 97	
these results led to the conclusion that they are SUMOylated H2A.Z-2 forms (Fig. 1, lanes 1-98	
4).  99	
 Previous studies have reported that PIAS4, a SUMO E3-ligase, is required for the 100	
accumulation of SUMO1 at sites with DNA damage, 23 raising the possibility that PIAS4 is 101	
responsible for the SUMOylation of H2A.Z-2. To address this, we next examined the 102	
physical interaction between PIAS4 and H2A.Z-2. By immunoblotting using anti-PIAS4 103	
antibodies, we found that PIAS4 was also present in the purified H2A.Z-2 complex, 104	
indicating its association with H2A.Z-2. Importantly, the association of H2A.Z-2 with PIAS4 105	
was increased by irradiation (Fig. 1, lanes 5 and 6). 106	
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 To confirm that the above-mentioned DNA damage-dependent SUMOylation of 107	
H2A.Z-2 was actually mediated by PIAS4, we examined the effect of PIAS4 depletion on the 108	
SUMOylation of H2A.Z-2. To do so, we established HeLa cells in which PIAS4 is depleted 109	
by shRNA-mediated downregulation, and subsequently performed the immunoblotting 110	
analysis. As shown in Fig. 2, significant decreases of the SUMOylated H2AZ-2 were detected 111	
both before and after DNA damage (indicated by arrows), indicating that PIAS4 is the E3-112	
ligase involved in the SUMOylation of H2A.Z-2. Remarkably, the H2AZ-2 SUMOylation 113	
after irradiation was nearly abolished by the PIAS4 depletion (relative intensity of SUMO1 114	
reduced from 1.75 to 0.29), suggesting that the DNA damage-induced SUMOylation of 115	
H2AZ-2 is predominantly mediated by PIAS4 (Fig. 2). 116	
We have previously shown that H2A.Z-2 is exchanged at DSB sites. 15 To examine 117	
whether the SUMOylation of H2A.Z-2 plays a key role in the dynamics of this exchange, we 118	
performed fluorescence recovery after photobleaching (FRAP) in combination with UVA-119	
microirradiation, using cells transiently expressing GFP-fused H2A.Z-2 together with the 120	
shRNA against either PIAS4 or PIAS1 (Fig. 3A). The cells were first microirradiated (Fig. 3B, 121	
red boxes) and then photobleached (Fig. 3B, yellow boxes), to analyze the recovery of the 122	
fluorescent signal in the bleached area. Significant fluorescence recovery of the GFP-H2A.Z-123	
2 signal was observed after microirradiation (Fig. 3C, red line), but not within the unirradiated 124	
areas, in the mock-shRNA transfected cells as reported previously (Fig. 3C, blue line). 15 In 125	
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contrast, the fluorescence recovery of the GFP-H2A.Z-2 signal after microirradiation was 126	
significantly repressed in the PIAS4 shRNA-expressing cells (fluorescence recovery in the 127	
damaged area at 270 seconds after photobleaching is 13.8% ± 6.3%, with a P value of <0.001 128	
between mock shRNA and shPIAS4, and fluorescence recovery in the non-damaged area is 129	
8.3% ± 3.8%) (Fig. 3C and D). Another SUMO E3-ligase, PIAS1, also reportedly accumulates 130	
at DSB sites and promotes DNA damage responses. 23 However, the PIAS1 depletion failed to 131	
repress the fluorescence recovery of the GFP-H2A.Z-2 signal at the microirradiated area. These 132	
findings suggest that PIAS4, but not PIAS1, facilitates the incorporation of H2A.Z-2 at 133	
damaged sites.  134	
Next, we examined whether PIAS4 regulates the eviction of GFP-H2A.Z-2 from the 135	
microirradiated area, by an inverse FRAP analysis. 15 In the inverse FRAP analysis, the cells 136	
were first microirradiated (Fig. 3D, red boxes) and then photobleached (Fig. 3D, yellow 137	
boxes, excluding small interior boxes). The loss of fluorescence from the unbleached area 138	
was monitored and quantified. Consistent with our previous report, the intensity of the 139	
remaining GFP-H2A.Z-2 fluorescent signal was decreased in the irradiated areas, but not in 140	
the unirradiated areas in the mock shRNA-expressing cells (Fig. 3D and E). 15 The inverse 141	
FRAP analysis of the PIAS4 shRNA-expressing cells revealed that the intensity of the 142	
remaining GFP-H2A.Z-2 fluorescent signal from the unbleached area was not significantly 143	
decreased in the irradiated areas, as compared to that in the mock shRNA-expressing cells 144	
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(Fig. 3D and E). These findings indicate that PIAS4 facilitates the eviction of H2A.Z-2 from 145	
damaged chromatin. Taken together with the findings obtained by the FRAP analysis, these 146	
results strongly suggest that the PIAS4 mediated-SUMOylation of H2AZ-2 regulates the 147	
exchange of H2A.Z-2 at DNA damage sites. 148	
 149	
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Discussion 151	
Reorganization of damaged chromatin plays an important role in the regulation of the DNA 152	
damage response. In our previous study, we found that H2A.Z-2 is exchanged at damaged 153	
sites. 15 In this study, we showed that the SUMO modification system positively regulates the 154	
DNA damage-dependent exchange of the histone variant H2A.Z-2 at damaged sites. We also 155	
found that H2A.Z-2 is SUMOylated by PIAS4 in a DNA damage-dependent manner. These 156	
findings suggest that the SUMO modification system facilitates the exchange of H2A.Z-2 at 157	
damaged sites. 158	
 In our previous study, we showed that H2A.Z-2 is required for the DNA damage-159	
dependent RAD51 focus formation. 15 RAD51, a key recombinase in HR, has a SUMO-160	
interacting motif (SIM) that is necessary for its accumulation at sites of DNA damage, and 161	
requires PIAS4 for this localization. 24 In this study, we showed that PIAS4 is also 162	
responsible for the SUMOylation of H2A.Z-2. Taken together, these findings suggest that the 163	
DNA damage-dependent SUMOylation by PIAS4 facilitates the RAD51 focus formation, 164	
through the reorganization of damaged chromatin by the exchange of H2A.Z-2. 165	
 Recent studies have revealed the role of the post-translational modifications of H2A.Z 166	
in the regulation of DNA metabolism. The acetylation of H2A.Z contributes to transcriptional 167	
activation. 26 27 TIP60 is involved in the acetylation of H2A.Z, as well as H2A and H4. 28 The 168	
lysine methyltransferase SETD6 monomethylates lysine 7 of H2A.Z, which is involved in the 169	
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negative regulation of gene expression. 29 Monoubiquitinated H2A.Z is enriched on the inactive 170	
X chromosome, suggesting that ubiquitinated H2A.Z is associated with transcriptional 171	
silencing. 30 In contrast to these modifications involved in gene expression, the SUMOylation 172	
of H2A.Z is required for DSB recruitment to the nuclear periphery in yeast. 22 In our present 173	
study, we demonstrated that the SUMOylation of H2A.Z in human cells is also involved in the 174	
positive regulation of DNA repair. Although the means by which the SUMOylation of H2A.Z-175	
2 in human cells facilitates the RAD51 focus formation remain to be clarified, these findings 176	
suggest the conserved function of the SUMOylation of H2A.Z to facilitate DNA repair, from 177	
yeast to human. 178	
 H2A.Z-1 and H2A.Z-2 differ by only three amino acids, but they are encoded by unique 179	
nucleotide sequences. 13 Chicken DT40 cells with either the H2A.Z-1 or H2A.Z-2 gene knock-180	
out exhibit distinct alterations in gene expression and cell proliferation. 14 The H2A.Z-2 181	
deficiency sensitizes malignant melanoma cells to chemotherapy and targeted therapy. 11 The 182	
nucleosomal H2A.Z-1 is more rapidly exchanged than H2A.Z-2 under normal conditions. 31 In 183	
contrast, H2A.Z-2 exhibits higher mobility than H2A.Z-1 after DSB induction. 15 In this study, 184	
we showed that the SUMO modification system regulates the dynamics of H2A.Z-2 at DNA 185	
damage sites. The DNA damage-induced exchange of SUMOylated H2A.Z-2 may play a role 186	
to accelerate the accumulation of the SUMO-interacting DNA repair proteins at damaged sites. 187	
Although further explorations are required to clarify the interaction between RAD51 with 188	
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H2A.Z-2, the focus formation of RAD51 could be facilitated by this DNA damage-dependent 189	
exchange of SUMOylated H2A.Z-2. Interestingly, H2AX, another histone H2A variant, is also 190	
exchanged after the induction of DSBs, to allow PARP-1 accumulation at damaged sites. 32 The 191	
exchange of histone variants H2AX and H2A.Z-2 may play an important role in DNA repair 192	
to facilitate the intra-nuclear transport of repair proteins to the damaged sites. 193	
 194	
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Materials and Methods 196	
 197	
Cell culture and ionizing irradiation 198	
GM0637 cells were cultured in Dulbecco’s modified Eagle’s medium (Sigma-Aldrich), 199	
supplemented with 10% fetal bovine serum (Equitech-Bio). HeLa cells were cultured in 200	
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum and 0.2 201	
mg/ml G418 (Gibco). For ionizing irradiation treatment, cells were irradiated with 137Cs γ-rays, 202	
using a Gammacell 40 system (MDS Nordion, Ottawa, Canada) at 10 Gy. 203	
 204	
Protein affinity purification 205	
To prepare the FLAG-HA-tagged H2A.Z-2 complex, nuclei were collected by centrifugation 206	
at 3,900 rpm for 15 minutes after a treatment with hypotonic buffer, as previously described. 207	
33 After resuspension of the pellet in an equal volume of sucrose buffer (0.34 M sucrose, 10 208	
mM Tris-HCl, pH 7.3, 3 mM MgCl2, 100 mM MEM), 1× sucrose buffer was added to adjust 209	
the volume to a final DNA concentration of 2 mg/ml. Micrococcal nuclease was added at 25 210	
U/ mg DNA. The samples were incubated at 37°C for 20 minutes, and the reactions were then 211	
stopped by adding 4 mM EDTA. The samples were centrifuged at 14,000 rpm at 4°C for 30 212	
minutes. After dialysis, the supernatant was used as the solubilized FLAG-HA-tagged H2A.Z-213	
2-containing chromatin fraction. FLAG-HA-tagged H2A.Z-2 proteins were purified by 214	
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immunoaffinity purification with an immobilized anti-FLAG antibody, and were eluted with 215	
FLAG peptide as described previously. 25 The knockdown of PIAS4 was performed by the 216	
expression of pSuper-retro-PIAS4 by a retroviral vector. Whole-cell lysates were used as the 217	
input. All buffers contained 100 mM N-ethylmaleimide (Sigma-Aldrich), to prevent 218	
deSUMOylation by SUMO proteases. 219	
 220	
Immunoblotting 221	
Protein extracts were resolved by sodium dodecyl sulfate (SDS)–polyacrylamide gel 222	
electrophoresis and transferred to nitrocellulose membranes. The membranes were blocked 223	
with Blocking One (Nacalai Tesque, Inc.) for 60 minutes at room temperature. The primary 224	
antibodies, diluted in Phosphate Buffered Saline (PBS) with Tween® 20, were incubated with 225	
the membranes for 60 minutes at room temperature. The membranes were subsequently washed 226	
and incubated with horseradish peroxidase-conjugated secondary antibodies for 60 minutes at 227	
room temperature. Band intensities were quantified by densitometry (Image J software) and 228	
normalized to those of β-actin, serving as the loading control. The intensities were calculated 229	
relative to that of the control (Mock-No IR), which was set to 1.0. 230	
 231	
Antibodies 232	
Rabbit anti-H2A.Z (cat# ab4174, Abcam), rabbit anti-SUMO1 (cat# sc-9060, Santa Cruz 233	
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Biotechnology), rabbit anti-PIAS1 (cat# ab32219, Abcam), rabbit anti-PIAS4 (cat# ab58416, 234	
Abcam), mouse anti-β-actin (cat# A5441, Sigma-Aldrich) and goat anti-rabbit Alexa Fluor 488 235	
(cat# A11008, Life Technologies) were used in the experiments. 236	
 237	
UVA-microirradiation, FRAP and iFRAP 238	
Imaging, microirradiation, and fluorescence recovery after photobleaching (FRAP) 239	
experiments were performed using an LSM780 confocal microscope (Carl Zeiss), with a 63× 240	
1.40 NA plan-apochromat objective. Cells were placed in no. 1S glass-bottom dishes 241	
(Matsunami Glass Ind., Ltd.). For microirradiation, sensitization of cells was performed by 242	
incubating the cells for 24 hours in medium containing 2.5 µM deoxyribosylthymine and 0.3 243	
µM bromodeoxyuridine (Sigma-Aldrich) and then staining with 2 µg/ml Hoechst 33258 244	
(Sigma-Aldrich) for 10 minutes before UVA microirradiation, as described previously. 34 The 245	
Dulbecco’s modified Eagle’s medium was replaced by Leibovitz’s L-15 (Gibco) containing 246	
10% fetal bovine serum and 25 mM HEPES (Gibco), just before microirradiation. During 247	
imaging, the dishes were kept in a humidified cell culture incubator with a continuous supply 248	
of 5% CO2/air at 37°C (Tokai Hit). The 355-nm line of the UVA laser was used for 249	
microirradiation (six pulses at 4.43 W). The maximum power of the 488-nm Ar laser line was 250	
used for photobleaching in the FRAP analysis. For imaging, the laser was attenuated to 0.1%. 251	
All fluorescent regions, except for small regions in the irradiated and unirradiated areas, were 252	
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bleached, and the remaining GFP fluorescence was monitored with the LSM780 confocal 253	
microscope. For the FRAP and iFRAP analyses, a prebleached image was acquired just after 254	
the induction of DSBs by UVA laser microirradiation, after which the bleaching pulse was 255	
delivered. To quantify the fluorescence recovery, single optical sections were collected at 3-s 256	
intervals for the indicated periods of time. ImageJ was used for fluorescent intensity 257	
quantification in the FRAP and iFRAP analyses. The relative intensities in the bleached area 258	
were measured and normalized by the average intensity before bleaching. The percent recovery 259	
(relative intensity) at each time point was calculated as: P recovery; t=100×(I rel; t-I rel; 1.5s)/(1-I rel; 260	
1.5s), where I rel; 1.5s was the relative intensity of the bleached area in the first image obtained 261	
after bleaching. 262	
 263	
Immunofluorescence microscopy 264	
Cells were fixed with PBS containing 2% paraformaldehyde for 10 minutes at room 265	
temperature, and permeabilized with PBS containing 0.5% Triton X-100 for 10 minutes at room 266	
temperature. The cells were then incubated with antibodies in PBS containing 1% BSA, at 267	
37°C for 30 minutes. Nuclei were stained with DAPI. The cells were mounted using 268	
Vectashield and observed on an Axioplan2 microscope with AxioCam MRm, controlled by the 269	
AxioVision software (Carl Zeiss). 270	
 271	
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RNAi 272	
The pSIREN-DNR-DsRed-Express vector (Clontech) was used for PIAS1 and PIAS4 RNAi. 273	
The target sequences were 5'-CGAAUGAACUUGGCAGAAA-3' (PIAS1) and 5'-274	
AGGCACUGGUCAAGGAGAA-3' (PIAS4). 275	
 276	
Statistical analysis 277	
Data were compared using the Student t-test. 278	
 279	
  280	
	 18	
Disclosure of Potential Conflicts of Interest 281	
No potential conflicts of interest were disclosed. 282	
 283	
Acknowledgments 284	
We thank A. Kinomura for technical assistance. 285	
 286	
Funding 287	
This research was supported by JSPS KAKENHI Grants, number JP26430114 to J.S., 288	
number JP25116009 to M.H. and numbers JP16H01312 and JP15H02821 to S.T. This work 289	
was partially supported by the Program of the network-type joint Usage/Research Center for 290	
Radiation Disaster Medical Science of Hiroshima University, Nagasaki University, and 291	
Fukushima Medical University.  292	
 293	
  294	
	 19	
References 295	
1. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 296	
2009; 461:1071-8. 297	
2. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical 298	
role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol : 299	
CB 2000; 10:886-95. 300	
3. Mizuguchi G, Shen X, Landry J, Wu WH, Sen S, Wu C. ATP-driven exchange of histone 301	
H2AZ variant catalyzed by SWR1 chromatin remodeling complex. Science (New York, NY) 2004; 302	
303:343-8. 303	
4. Horigome C, Oma Y, Konishi T, Schmid R, Marcomini I, Hauer MH, et al. SWR1 and INO80 304	
chromatin remodelers contribute to DNA double-strand break perinuclear anchorage site choice. 305	
Mol Cell 2014; 55:626-39. 306	
5. Xu Y, Ayrapetov MK, Xu C, Gursoy-Yuzugullu O, Hu Y, Price BD. Histone H2A.Z controls 307	
a critical chromatin remodeling step required for DNA double-strand break repair. Mol Cell 2012; 308	
48:723-33. 309	
6. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W. Histone H2A variants 310	
H2AX and H2AZ. Curr Opin Genet Dev 2002; 12:162-9. 311	
7. Faast R, Thonglairoam V, Schulz TC, Beall J, Wells JR, Taylor H, et al. Histone variant 312	
H2A.Z is required for early mammalian development. Curr Biol : CB 2001; 11:1183-7. 313	
8. Morillo-Huesca M, Clemente-Ruiz M, Andujar E, Prado F. The SWR1 histone replacement 314	
complex causes genetic instability and genome-wide transcription misregulation in the absence of 315	
H2A.Z. PLoS One 2010; 5:e12143. 316	
9. Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, Russell BA, et al. Genomic analysis of 317	
estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol 318	
Syst Biol 2008; 4:188. 319	
10. Kim K, Punj V, Choi J, Heo K, Kim JM, Laird PW, et al. Gene dysregulation by histone 320	
variant H2A.Z in bladder cancer. Epigenetics & chromatin 2013; 6:34. 321	
11. Vardabasso C, Gaspar-Maia A, Hasson D, Punzeler S, Valle-Garcia D, Straub T, et al. 322	
Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma. Mol 323	
Cell 2015; 59:75-88. 324	
12. Millar CB, Xu F, Zhang K, Grunstein M. Acetylation of H2AZ Lys 14 is associated with 325	
genome-wide gene activity in yeast. Genes Dev 2006; 20:711-22. 326	
13. Eirin-Lopez JM, Gonzalez-Romero R, Dryhurst D, Ishibashi T, Ausio J. The evolutionary 327	
differentiation of two histone H2A.Z variants in chordates (H2A.Z-1 and H2A.Z-2) is mediated by 328	
a stepwise mutation process that affects three amino acid residues. BMC Evol Biol 2009; 9:31. 329	
14. Matsuda R, Hori T, Kitamura H, Takeuchi K, Fukagawa T, Harata M. Identification and 330	
characterization of the two isoforms of the vertebrate H2A.Z histone variant. Nucleic Acids Res 331	
	 20	
2010; 38:4263-73. 332	
15. Nishibuchi I, Suzuki H, Kinomura A, Sun J, Liu NA, Horikoshi Y, et al. Reorganization of 333	
damaged chromatin by the exchange of histone variant H2A.Z-2. Int J Radiat Oncol Biol Phys 334	
2014; 89:736-44. 335	
16. Kurdistani SK, Grunstein M. Histone acetylation and deacetylation in yeast. Nat Rev Mol 336	
Cell Biol 2003; 4:276-84. 337	
17. Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. 338	
Nat Rev Genet 2012; 13:343-57. 339	
18. Rossetto D, Avvakumov N, Cote J. Histone phosphorylation: a chromatin modification 340	
involved in diverse nuclear events. Epigenetics 2012; 7:1098-108. 341	
19. Weake VM, Workman JL. Histone ubiquitination: triggering gene activity. Mol Cell 2008; 342	
29:653-63. 343	
20. Shiio Y, Eisenman RN. Histone sumoylation is associated with transcriptional repression. 344	
Proc Natl Acad Sci USA 2003; 100:13225-30. 345	
21. Hay RT. SUMO: a history of modification. Mol Cell 2005; 18:1-12. 346	
22. Kalocsay M, Hiller NJ, Jentsch S. Chromosome-wide Rad51 spreading and SUMO-H2A.Z-347	
dependent chromosome fixation in response to a persistent DNA double-strand break. Mol Cell 348	
2009; 33:335-43. 349	
23. Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller KM, Jackson SP. Mammalian 350	
SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 351	
2009; 462:935-9. 352	
24. Shima H, Suzuki H, Sun J, Kono K, Shi L, Kinomura A, et al. Activation of the SUMO 353	
modification system is required for the accumulation of RAD51 at sites of DNA damage. J Cell Sci 354	
2013; 126:5284-92. 355	
25. Nakatani Y, Ogryzko V. Immunoaffinity purification of mammalian protein complexes. 356	
Methods Enzymol 2003; 370:430-44. 357	
26. Valdes-Mora F, Song JZ, Statham AL, Strbenac D, Robinson MD, Nair SS, et al. Acetylation 358	
of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic 359	
remodeling in cancer. Genome Res 2012; 22:307-21. 360	
27. Kusakabe M, Oku H, Matsuda R, Hori T, Muto A, Igarashi K, et al. Genetic 361	
complementation analysis showed distinct contributions of the N-terminal tail of H2A.Z to 362	
epigenetic regulations. Genes Cells 2016; 21:122-35. 363	
28. Dalvai M, Bellucci L, Fleury L, Lavigne AC, Moutahir F, Bystricky K. H2A.Z-dependent 364	
crosstalk between enhancer and promoter regulates cyclin D1 expression. Oncogene 2013; 32:4243-365	
51. 366	
29. Binda O, Sevilla A, LeRoy G, Lemischka IR, Garcia BA, Richard S. SETD6 monomethylates 367	
H2AZ on lysine 7 and is required for the maintenance of embryonic stem cell self-renewal. 368	
Epigenetics 2013; 8:177-83. 369	
	 21	
30. Sarcinella E, Zuzarte PC, Lau PN, Draker R, Cheung P. Monoubiquitylation of H2A.Z 370	
distinguishes its association with euchromatin or facultative heterochromatin. Mol Cell Biol 2007; 371	
27:6457-68. 372	
31. Horikoshi N, Sato K, Shimada K, Arimura Y, Osakabe A, Tachiwana H, et al. Structural 373	
polymorphism in the L1 loop regions of human H2A.Z.1 and H2A.Z.2. Acta Crystallogr D Biol 374	
Crystallogr 2013; 69:2431-9. 375	
32. Ikura M, Furuya K, Fukuto A, Matsuda R, Adachi J, Matsuda T, et al. Coordinated 376	
Regulation of TIP60 and Poly(ADP-Ribose) Polymerase 1 in Damaged-Chromatin Dynamics. Mol 377	
Cell Biol 2016; 36:1595-607. 378	
33. Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y. Histone H3.1 and H3.3 complexes 379	
mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 2004; 380	
116:51-61. 381	
34. Walter J, Cremer T, Miyagawa K, Tashiro S. A new system for laser-UVA-microirradiation 382	
of living cells. J Microsc 2003; 209:71-5. 383	
 384	
  385	
	 22	
Figure legends 386	
 387	
Figure 1. The H2A.Z-2 complex, purified from the nuclear soluble fraction of HeLa cells, was 388	
subjected to immunoblot analyses using anti-H2A.Z (lanes 1 and 2), anti-SUMO1 (lanes 3 and 389	
4), anti-PIAS4 (lanes 5 and 6) and anti-PIAS1 (lanes 5 and 6) antibodies. DNA damage was 390	
induced by 10 Gy IR, followed by a 10-minute recovery. The arrows indicate SUMOylated 391	
H2A.Z-2 and the asterisks indicate unmodified H2A.Z-2. Whole-cell lysates were used as the 392	
input. 393	
 394	
Figure 2. The H2A.Z-2 complex, purified from the nuclear soluble fraction of HeLa cells 395	
stably expressing mock shRNA or shPIAS4, was subjected to immunoblot analyses using anti-396	
H2A.Z and anti-SUMO1 antibodies. The amounts of PIAS4 and control β-actin in the input 397	
materials were detected by immunoblotting with the respective antibodies. DNA damage was 398	
induced by 10 Gy IR, followed by a 10-minute recovery. The arrows indicate SUMOylated 399	
H2A.Z-2 and the asterisks indicate unmodified H2A.Z-2. SUMOylated H2A.Z-2 protein levels 400	
were calculated as the relative intensity with respect to β-actin. Whole-cell lysates were used 401	
as the input. 402	
 403	
Figure 3. (A) Depletion of PIAS4 or PIAS1 by pSIREN-shRNA. Cells expressing pSIREN-404	
	 23	
shRNA are DsRed-positive. Endogenous PIAS4 and PIAS1 were detected by 405	
immunofluorescence staining with the respective antibodies. DsRed, PIAS4 and DNA (DAPI) 406	
are shown in red, green and blue, respectively, in the merged images. Scale bars: 10 µm. (B) 407	
FRAP analysis to monitor the incorporation of H2A.Z-2 at damage sites. GM0637 cells 408	
transiently expressing GFP-H2A.Z-2 and pSIREN-mock, PIAS4 or PIAS1 shRNA were first 409	
microirradiated (red boxes) and then photobleached (yellow boxes). (C) The fluorescence 410	
recovery of the cells in (B) was monitored as previously described. 15 (D) Inverse FRAP 411	
analysis to monitor the eviction of H2A.Z-2 at damage sites. GM0637 cells transiently 412	
expressing GFP-H2A.Z-2 and pSIREN-mock or PIAS4 shRNA were first microirradiated (red 413	
boxes) and then photobleached (yellow boxes, excluding small interior boxes). (E) The relative 414	
intensity of the cells in (D) was monitored as previously described. 15 415	
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